Recherches sur le développement des organes genitaux de quelques Gasteropodes hermaphrodites. 1. Thèse ; Propositions données par la Faculté. 2e. Thèse

(PDF contains 82 pages

Foissac – Perte de la Jonquière

Date de l'opération : 1978 - 1988 (FP) Inventeur(s) : Rouzaud François À l'issue de onze années de recherches codirigées par S. Cours, Henri Duday, M. Garcia et François Rouzaud, les opérations de fouilles ont été arrêtées en1988, avec l'aboutissement du programme initialement prévu. Découverte en 1965, la grotte de Foissac a été aménagée par les spéléologues inventeurs et ouverte au public en 1973. La partie accessible aux visiteurs correspond à celle investie par les Chalcolithiques, elle ..

Inscription trouvée près de Bizanet (Aude) et dédiée aux « limites » personnifiées

Rouzaud Henri. Inscription trouvée près de Bizanet (Aude) et dédiée aux « limites » personnifiées. In: Comptes rendus des séances de l'Académie des Inscriptions et Belles-Lettres, 57ᵉ année, N. 8, 1913. pp. 660-663

Chronique gallo-romaine

Rouzaud H., Jullian Camille. Chronique gallo-romaine. In: Revue des Études Anciennes. Tome 16, 1914, n°4. pp. 432-437

Chronique gallo-romaine

Rouzaud H., Jullian Camille. Chronique gallo-romaine. In: Revue des Études Anciennes. Tome 16, 1914, n°4. pp. 432-437

La crise de la pilule en France : vers un nouveau modèle contraceptif ?

Le débat médiatique de fin 2012 - début 2013 sur les pilules n’a pas entraîné de désaffection vis-à-vis de la contraception mais le recours à la contraception orale a diminué, passant de 50 % en 2010 à 41 % en 2013. Une partie des femmes ayant opté pour d’autres méthodes, notamment le stérilet (pour les plus diplômées), le préservatif ou des méthodes dites naturelles (pour les plus précaires). De nouvelles inégalités sociales vis-à-vis du recours à la contraception sont par ailleurs apparues. Le débat de 2013 a contribué à une diversification des pratiques contraceptives, même si la pilule reste prépondérante

The French pill scare : towards a new contraceptive model?

The media debate in late 2012 and early 2013 on contraceptive pills did not reduce contraceptive prevalence,but the use of oral contraception decreased, falling from 50% in 2010 to 41% in 2013. A portion of women opted for other methods, notably IUDs (among the most educated), condoms, or "natural" methods (among the most disadvantaged). New social inequalities in contraceptive use appeared. The 2013 debate contributed to a diversification of contraceptive practices, although the pill remains dominant

The French pill scare and the reshaping of social inequalities in access to medical contraceptives

While the consequences of various "pill scares" have been relatively well-documented in the public health literature revealing a drop in pill use and a rise in unplanned pregnancies and abortion rates, researchers rarely considered that these controversies would affect women contraceptive practices differently according to their social background. Indeed, social differentiations in reaction to "pill scares" could contribute to reinforce the social gradient in the use of contraceptive methods and choice of visiting the health professionals who prescribe them. These could contribute to an increase in health inequalities on access to contraceptive methods. Using data from three state nationally representative cross-sectional surveys conducted in France in 2010, 2013 and 2016, we studied the changes in women's contraceptive uses around the French "pill scare" that occurred in 2012–2013. We focused on the changes in the use of all contraceptives available under medical prescription (called medical contraceptives) on one hand, and on each specific method (pill, IUD, implant, patch or vaginal ring, and female sterilization) on the other hand according to the women's social background. We saw a social gradient in contraceptives changes. The decline in the use of contraceptive methods available under medical prescription was particularly marked for women from lower and higher classes in which we observe a decrease in pill use between 2010 and 2013, whereas it was observed only between 2013 and 2016 among middle class women. Moreover, while some women from upper class shifted from pill to IUD between 2010 and 2013, this was not the case for their less privileged counterparts. As a consequence, it seems that the French "pill scare" led to the reshaping of social inequalities in access to medical contraceptives

The French pill scare and the reshaping of social inequalities in access to medical contraceptives

While the consequences of various “pill scares” have been relatively well-documented in the public health literature revealing a drop in pill use and a rise in unplanned pregnancies and abortion rates, researchers rarely considered that these controversies would affect women contraceptive practices differently according to their social background. Indeed, social differentiations in reaction to “pill scares” could contribute to reinforce the social gradient in the use of contraceptive methods and choice of visiting the health professionals who prescribe them. These could contribute to an increase in health inequalities on access to contraceptive methods. Using data from three state nationally representative cross-sectional surveys conducted in France in 2010, 2013 and 2016, we studied the changes in women's contraceptive uses around the French “pill scare” that occurred in 2012–2013. We focused on the changes in the use of all contraceptives available under medical prescription (called medical contraceptives) on one hand, and on each specific method (pill, IUD, implant, patch or vaginal ring, and female sterilization) on the other hand according to the women's social background. We saw a social gradient in contraceptives changes. The decline in the use of contraceptive methods available under medical prescription was particularly marked for women from lower and higher classes in which we observe a decrease in pill use between 2010 and 2013, whereas it was observed only between 2013 and 2016 among middle class women. Moreover, while some women from upper class shifted from pill to IUD between 2010 and 2013, this was not the case for their less privileged counterparts. As a consequence, it seems that the French “pill scare” led to the reshaping of social inequalities in access to medical contraceptives

Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea.

Complex cutaneous and muco-cutaneous leishmaniasis (CL and MCL) often requires systemic therapy. Liposomal amphotericin B (L-AmB) has a strong potential for a solid clinical benefit in this indication.We conducted a retrospective analysis of data from a French centralized referral treatment program and from the "LeishMan" European consortium database. All patients with parasitologically proven CL or MCL who received at least one dose of L-AmB were included. Positive outcome was based on ulcer closure as per recent WHO workshop guidelines.From 2008 through 2016, 43 travelers returning from 18 countries (Old World n = 28; New World n = 15) were analyzed with a median follow-up duration of 79 days [range 28-803]. Main clinical forms were: localized CL with one or multiple lesions (n = 32; 74%) and MCL (n = 8; 19%). As per published criteria 19 of 41 patients (46%) were cured 90 days after one course of L-AmB. When the following items -improvement before day 90 but no subsequent follow-up, delayed healing (>3 months) and healing after a second course of L-AmB- were included in the definition of cure, 27 of 43 patients (63%) had a positive outcome. Five patients (MCL = 1; CL = 4) experienced a relapse after a median duration of 6 months [range 3-27] post treatment and 53% of patients (23/43) experienced at least one adverse event including severe hypokalaemia and acute cardiac failure (one patient each). In multivariate analysis, tegumentary infection with L. infantum was associated with complete healing after L-AmB therapy (OR 5.8 IC 95% [1.03-32]) while infection with other species had no impact on outcome.In conditions close to current medical practice, the therapeutic window of L-AmB was narrow in travellers with CL or MCL, with the possible exception of those infected with L. infantum. Strict follow-up is warranted when using L-AmB in patients with mild disease